Deep learning uncovers histological patterns of YAP1/TEAD activity related to disease aggressiveness in cancer patients
Author:
Schmauch Benoit, Cabeli Vincent, Domingues Omar Darwiche, Douget Jean-Eudes Le, Hardy Alexandra, Belbahri Reda, Maussion Charles, Romagnoni Alberto, Eckstein Markus, Fuchs Florian, Swalduz Aurélie, Lantuejoul Sylvie, Crochet Hugo, Ghiringhelli François, Derangere Valentin, Truntzer Caroline, Pass Harvey, Moreira Andre L., Chiriboga Luis, Zheng YuanningORCID, Ozawa Michael, Howitt Brooke E., Gevaert OlivierORCID, Girard Nicolas, Rexhepaj Elton, Valtingojer Iris, Debussche Laurent, de Rinaldis Emanuele, Nestle Frank, Spanakis Emmanuel, Fantin Valeria R., Durand Eric Y., Classe Marion, Loga Katharina Von, Pronier Elodie, Cesaroni Matteo
Abstract
SummaryOver the last decade, Hippo signaling has emerged as a major tumor-suppressing pathway. Its dysregulation is associated with abnormal expression ofYAP1andTEAD-family genes. Recent works have highlighted the role of YAP1/TEAD activity in several cancers and its potential therapeutic implications. Therefore, identifying patients with a dysregulated Hippo pathway is key to enhancing treatment impact. Although recent studies have derived RNAseq-based signatures, there remains a need for a reproducible and cost-effective method to measure the pathway activation. In recent years, deep learning applied to histology slides have emerged as an effective way to predict molecular information from a data modality available in clinical routine. Here, we trained models to predict YAP1/TEAD activity from H&E-stained histology slides in multiple cancers. The robustness of our approach was assessed in seven independent validation cohorts. Finally, we showed that histological markers of disease aggressiveness were associated with dysfunctional Hippo signaling.
Publisher
Cold Spring Harbor Laboratory
|
|